Abstract
THE APO-l/(Fas/CD95) cell surface receptor is a member of the nerve growth factor (NGF)/tumour necrosis factor (TNF) receptor superfamily and mediates apoptosis1 –4. Peripheral activated T cells (ATC) from lymphoproliferation (Ipr/lpr) mutant mice that express a reduced number of APO-1 receptors have a defect in T-cell receptor (TCR)-induced apoptosis5,6. This suggests that TCR-induced apoptosis involves APO-1. We tested this hypothesis in various human T cells: (1) malignant Jurkat cells, (2) an allo-reactive T-cell clone (S13), and (3) peripheral ATC. TCR triggering through immobilized anti-CD3 antibodies or Staphylococcus enterotoxin B (SEB) superantigen induced expression of the APO-1 ligand and apoptosis in these cells. Anti-CD3-induced apoptosis of Jurkat cells was demonstrated even in single-cell cultures. In all cases apoptosis was substantially inhibited by blocking anti-APO-1 antibody fragments and soluble APO-1 receptor decoys. The APO-1 ligand was found in the supernatant of activated Jurkat cells as a soluble cytokine. We propose that TCR-induced apoptosis in ATC can occur through an APO-1 ligand-mediated autocrine suicide. These results provide a mechanism for suppression of the immune response and for peripheral tolerance by T-cell deletion.
Similar content being viewed by others
References
Trauth, B. C. et al. Science 245, 301–304 (1989).
Yonehara, S., Ishii, A. & Yonehara, M. J. exp. Med. 169, 1747–1756 (1989).
ltoh, N. et al. Cell 66, 233–243 (1991).
Oehm, A. et al. J. biol. Chem. 267, 10709–10715 (1992).
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Nature 356, 314–317 (1992).
Russell, J. H., Rush, B., Weaver, C. & Wang, R. Proc. natn. Acad. Sci. U.S.A. 90, 4409–4413 (1993).
Russell, J. H. & Wang, R. Eur. J. Immun. 23, 2379–2382 (1993).
Ramsdell, F. et al. Eur. J. Immun. 24, 928–933 (1994).
Takahashi, T. et al. Cell 76, 969–976 (1994).
Lynch, D. et al. Immunity 1, 131–136 (1994).
Gillette-Ferguson, I. & Sidman, C. L. Eur. J. Immun. 24, 1181–1185 (1994).
Dhein, J. et al. J. Immun. 149, 3166–3173 (1992).
Vignaux, F. & Golstein, P. Eur. J. Immun. 24, 923–927 (1994).
Rouvier, E., Luciani, M. F. & Golstein, P. J. exp. Med. 177, 195–200 (1993).
Ju, S.-T., Cui, H., Panka, D. J., Ettinger, R. & Marshak-Rothstein, A. Proc. natn. Acad. Sci. U.S.A. 91, 4185–4189 (1994).
Hanabuchi, S. et al. Proc. natn. Acad. Sci. U.S.A. 91, 4930–4934 (1994).
Stalder, T., Hahn, S. & Erb, P. J. Immun. 152, 1127–1133 (1994).
Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Nature 370, 650–652 (1994).
Klas, C., Debatin, K.-M., Jonker, R. R. & Krammer, P. H. Int. Immun. 5, 625–630 (1993).
Nicoletti, I., Migliorati, M. C., Grignani, F. & Riccardi, C. J. J. immun. Meth. 139, 271–279 (1991).
Kabelitz, D., Conradt, P., Schondelmaier, S., Wagner, H. & Haas, R. J. exp. Med. 170, 559–569 (1989).
Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Cell 75, 1169–1178 (1993).
Peppel, K., Crawford, D. & Beutler, B. J. exp. Med. 174, 1483–1489 (1991).
Haight, F. A. Handbook of the Poisson Distribution (Wiley, New York, 1967).
Debatin, K.-M., Süss, D. & Krammer, P. H. Eur. J. Immun. 24, 753–758 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dhein, J., Walczak, H., Bäumler, C. et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438–441 (1995). https://doi.org/10.1038/373438a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/373438a0
- Springer Nature Limited
This article is cited by
-
FOXP3 protects conventional human T cells from premature restimulation-induced cell death
Cellular & Molecular Immunology (2021)
-
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
Nature Reviews Immunology (2021)
-
A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Journal of Neuroinflammation (2019)
-
CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target
Cancer Cell International (2019)
-
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Nature Communications (2019)